You are on page 1of 6

The Renin-Angiotensin-Aldosterone System

National Kidney Foundation KDOQI


Guidelines
Treatment of CKD in T2D
CREDENCE
Dedicated Renal Outcomes Trial With
Canagliflozin
The Role of Inflammation and Fibrosis
Phase 2 Clinical Trials With Finerenone
Abbreviations

You might also like